Meeting
2022 ASCO Annual Meeting
Analysis of MET exon 14 skipping mutations in non–small cell lung cancer (NSCLC) by histology and specific mutation.
Authors
Jennifer Aline Marks
Emory University School of Medicine, Atlanta, GA
Jennifer Aline Marks , Jun Yin , Balazs Halmos , Lyudmila Bazhenova , Suresh S. Ramalingam , Melina Elpi Marmarelis , Joanne Xiu , Phillip Walker , Matthew James Oberley , Patrick C. Ma , Stephen V. Liu
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Lung Cancer—Non-Small Cell Metastatic
Track
Lung Cancer
Sub Track
Metastatic Non–Small Cell Lung Cancer
Citation
J Clin Oncol 40, 2022 (suppl 16; abstr 9119)
DOI
10.1200/JCO.2022.40.16_suppl.9119
Abstract #
9119
Poster Bd #
105
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Updated molecular analysis of MET exon 14 skipping mutations (METex14) in non-small cell lung cancer (NSCLC).
First Author: Jennifer Aline Marks
Poster
2021 ASCO Annual Meeting
Prevalence of hyperprogressive disease (HPD) mutations and correlations to immune-related biomarkers in a large pan-cancer Chinese cohort.
First Author: Shengli Yang
Poster
2020 ASCO Virtual Scientific Program
The landscape of MAP3K1/MAP2K4 alterations in gastrointestinal (GI) malignancies.
First Author: Matthew K Stein
Poster
2023 ASCO Annual Meeting
The impact of PD-L1 expression and co-mutations on outcome of KRAS-driven non-small-cell lung cancer.
First Author: Petros Christopoulos